| 
      
        | Moxifloxacin Analytical Method    Validation-Assay |  
        | Method Parameter | Method Precision |  
        | Std. wt. & Dilution
 | 44.02 | 5 | Tablet Wt. | Spl. wt. & Dilution
 | Wt. of sample taken
 | 5 | Label claim (mg)
 | 400 |  
        | 100 | 20 | 675.01 | 200 | 200 | Potency (%) | 98.8 |  
        | Molecular factor for Moxifloxacin | 0.917 |  |  |  |  |  
        | Std. No. | Standards | USP Tailing
 | Weight of sample taken
 | Area of sample
 | Assay % | Average (%)
 | STDEV | % RSD |  
        | 1 | 2310915 | 1.54 | 1353.34 | 2337254 | 101.04 | 100.4 | 0.61837 | 0.62 |  
        | 2 | 2290693 | 1.54 | 1351.89 | 2321427 | 100.46 |  
        | 3 | 2300684 | 1.54 | 1358.15 | 2317128 | 99.81 |  
        | 4 | 2300777 | 1.54 | 1353.97 | 2341249 | 101.16 |  
        | 5 | 2300755 | 1.54 | 1355.02 | 2324067 | 100.34 |  
        |  |  |  | 1356.39 | 2310208 | 99.64 |  
        | Average | 2300765 | 1.54 | 1354.79 | 2325222 | 100.41 |  
        | STDEV | 7149.73 | 0.00 | Limits | % RSD of 6 replicate injections is not more than 2 |  
        | %RSD | 0.31 | 0.0 |  |